IL25 and neoplasm: IL-17E was expressed by tumor infiltrating CD4+ T cells and macrophages, and inhibition of IL-17E caused reduced tumor infiltration by both types of leucocytes, which was associated with a significantly disabled lung metastasis formation [99].